Tag: Biomedical Advanced Research and Development Authority

Trump tears into ’60 Minutes’ after segment with whistleblower Bright

President Trump took aim at CBS News and its flagship news magazine program, “60 Minutes,” on Sunday after the program interviewed whistleblower Rick Bright, former head of the Biomedical Advanced Research and Development Authority (BARDA).

In a tweet, the president excoriated CBS and its “third place anchor, @NorahODonnell,” whom he accused of “doing everything in their power to demean our Country, much to the benefit of the Radical Left Democrats.”

“Tonight they put on yet another Fake “Whistleblower”, a disgruntled employee who supports Dems, fabricates stories & spews lies. @60Minutes report was incorrect, which they couldn’t care less about. Fake News!” he tweeted.

“This whole Whistleblower racket needs to be looked at very closely, it is causing great injustice & harm. I hope you are listening [Sen. Susan Collins.] I also hope that Shari Redstone will take a look at her poorly performing gang. She knows how to make things right!” Trump added. Redstone is the chairwoman of ViacomCBS.

Bright, who last week slammed the Trump administration’s response to the COVID-19 crisis during testimony before the House Committee on Energy and Commerce, told CBS News that he was not “disgruntled,” as Trump has described him, but instead was frustrated with the administration’s response to the virus threat.

“Remember, the entire leadership was focused on containment. There was a belief that we could contain this virus and keep it out of the United States,” he said. “Containment doesn’t work. Containment does buy time. It could slow. It very well could slow the spread. But while you’re slowing the spread, you better be doing something in parallel to be prepared for when that virus breaks out. That was my job.”
“I am not disgruntled,” Bright added. “I am frustrated at a lack of leadership. I am frustrated at a lack of urgency to get a head start on developing lifesaving tools for Americans. I’m frustrated at our inability to be heard as scientists. Those things frustrate me.”

Bright told the House committee last week that “unprecedented illness and fatalities” would occur if the U.S. coronavirus response does not improve in upcoming months, and cast doubt on predictions that the U.S. would see a COVID-19 vaccine developed in the next year and a half.

[The Hill]

HHS ousts vaccine expert who pushed back on COVID-19 treatment

The former head of the office involved in developing a vaccine for COVID-19 said he was removed after he pushed to vet and to limit drug treatments often touted by President Trump. “Specifically, and contrary to misguided directives, I limited the broad use of chloroquine and hydroxychloroquine, promoted by the Administration as a panacea, but which clearly lack scientific merit,” Dr. Rick Bright said in a statement released by his lawyers Wednesday.

In tweets and public remarks, Mr. Trump has referred to hydroxychloroquine as a potential “game-changer” in treating COVID-19. The president has recommended the use of the antimalarial drug as a potential treatment for the coronavirus, despite limited evidence that the drug would be effective.

Bright was the director of the Biomedical Advanced Research and Development Authority (BARDA) and HHS deputy assistant secretary for preparedness and response by the administration.

He said that he was “involuntarily transferred to a more limited and less impactful position at the National Institutes of Health,” a transfer that he believes came in response to his “insistence that the government invest the billions of dollars allocated by Congress to address the COVID-19 pandemic into safe and scientifically vetted solutions, and not in drugs, vaccines and other technologies that lack scientific merit.”

“I am speaking out because to combat this deadly virus, science — not politics or cronyism — has to lead the way,” he said in his statement. Bright is a career official and not a political appointee. He has requested that the inspector general for the Department of Health and Human Services investigate his dismissal.

Bright said that he’s “prepared to look at all options and to think ‘outside the box’ for effective treatments,” but “I rightly resisted efforts to provide an unproven drug on demand to the American public.”

He demanded that the drugs only be used under a doctor’s supervision and only to “hospitalized patients with confirmed COVID-19” because of the “potentially serious risks associated with them, including increased mortality observed in some recent studies in patients with COVID-19.”

“Rushing blindly towards unproven drugs can be disastrous and result in countless more deaths. Science, in service to the health and safety of the American people, must always trump politics,” Bright said.

[CBS News]